These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6132630)

  • 1. Pharmacokinetics of two lorazepam formulations, oral and sublingual, after multiple doses.
    Caillé G; Spénard J; Lacasse Y; Brennan J
    Biopharm Drug Dispos; 1983; 4(1):31-42. PubMed ID: 6132630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic comparison of sublingual lorazepam with intravenous, intramuscular, and oral lorazepam.
    Greenblatt DJ; Divoll M; Harmatz JS; Shader RI
    J Pharm Sci; 1982 Feb; 71(2):248-52. PubMed ID: 6121043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical pharmacokinetics of lorazepam. I. Absorption and disposition of oral 14C-lorazepam.
    Greenblatt DJ; Schillings RT; Kyriakopoulos AA; Shader RI; Sisenwine SF; Knowles JA; Ruelius HW
    Clin Pharmacol Ther; 1976 Sep; 20(3):329-41. PubMed ID: 8232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics of lorazepam. II. Intramuscular injection.
    Greenblatt DJ; Joyce TH; Comer WH; Knowles JA; Shader RI; Kyriakopoulos AA; MacLaughlin DS; Ruelius HW
    Clin Pharmacol Ther; 1977 Feb; 21(2):222-30. PubMed ID: 13960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lormetazepam--plasma concentrations in volunteers following sublingual and oral dosing.
    Luscombe DK
    Psychopharmacology Suppl; 1984; 1():99-104. PubMed ID: 6147846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral contraceptives on triazolam, temazepam, alprazolam, and lorazepam kinetics.
    Stoehr GP; Kroboth PD; Juhl RP; Wender DB; Phillips JP; Smith RB
    Clin Pharmacol Ther; 1984 Nov; 36(5):683-90. PubMed ID: 6149030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical pharmacokinetics of lorazepam. III. Intravenous injection. Preliminary results.
    Greenblatt DJ; Comer WH; Elliott HW; Shader RI; Knowles JA; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):490-4. PubMed ID: 19508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of lorazepam: a review.
    Kyriakopoulos AA; Greenblatt DJ; Shader RI
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):16-23. PubMed ID: 30762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and bioavailability of intravenous, intramuscular, and oral lorazepam in humans.
    Greenblatt DJ; Shader RI; Franke K; MacLaughlin DS; Harmatz JS; Allen MD; Werner A; Woo E
    J Pharm Sci; 1979 Jan; 68(1):57-63. PubMed ID: 31453
    [No Abstract]   [Full Text] [Related]  

  • 10. Placebo-controlled comparative study of the anxiolytic activity and of the pharmacokinetics of oral and sublingual lorazepam in generalized anxiety.
    Spénard J; Caillé G; de Montigny C; Vézina M; Ouellette J; Larivière L; Trudel F
    Biopharm Drug Dispos; 1988; 9(5):457-64. PubMed ID: 3066417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lorazepam kinetics in the elderly.
    Greenblatt DJ; Allen MD; Locniskar A; Harmatz JS; Shader RI
    Clin Pharmacol Ther; 1979 Jul; 26(1):103-13. PubMed ID: 36252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relative bioavailability in humans for oral tablets and solutions of lormetazepam.
    Zecca L; Reina L; Scaglione F; Ferrario P; Pirola R; Ceccarelli G; Ciampini M; Fraschini F
    Arzneimittelforschung; 1985; 35(12):1870-2. PubMed ID: 2869762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single- and multiple-dose kinetics of oral lorazepam in humans: the predictability of accumulation.
    Greenblatt DJ; Allen MD; MacLaughlin DS; Huffman DH; Harmatz JS; Shader RI
    J Pharmacokinet Biopharm; 1979 Apr; 7(2):159-79. PubMed ID: 20218012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition pharmacokinetics of lorazepam in the rabbit.
    Nielsen-Kudsk F; Jakobsen P
    Acta Pharmacol Toxicol (Copenh); 1980 May; 46(5):388-91. PubMed ID: 6103631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability of intravenous and intramuscular lorazepam with an adjunct test of the inattention effect in humans.
    Nielsen-Kudsk F; Jensen TS; Magnussen I; Jakobsen P; Jensen PB; Mondrup K; Petersen T
    Acta Pharmacol Toxicol (Copenh); 1983 Feb; 52(2):121-7. PubMed ID: 6133404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single dose sublingual testosterone and oral sildenafil vs. a dual route/dual release fixed dose combination tablet: a pharmacokinetic comparison.
    Bloemers J; van Rooij K; de Leede L; Frijlink HW; Koppeschaar HP; Olivier B; Tuiten A
    Br J Clin Pharmacol; 2016 Jun; 81(6):1091-102. PubMed ID: 26804967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical pharmacokinetics of oxazepam and lorazepam.
    Greenblatt DJ
    Clin Pharmacokinet; 1981; 6(2):89-105. PubMed ID: 6111408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacodynamic correlates of modified absorption: studies with lormetazepam.
    Pierce DM; Franklin RA; Harry TV; Nicholson AN
    Br J Clin Pharmacol; 1984 Jul; 18(1):31-5. PubMed ID: 6146348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of cimetidine with oxazepam, lorazepam, and flurazepam.
    Greenblatt DJ; Abernethy DR; Koepke HH; Shader RI
    J Clin Pharmacol; 1984 Apr; 24(4):187-93. PubMed ID: 6144699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of lorazepam. IV. Long-term oral administration.
    Greenblatt DJ; Knowles JA; Comer WH; Shader RI; Harmatz JS; Ruelius HW
    J Clin Pharmacol; 1977; 17(8-9):495-500. PubMed ID: 19509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.